Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Nippon Indosari Corpindo Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan Nippon Indosari Corpindo Tbk. diperdagangkan di Rp610 (kapitalisasi pasar 3,8 T, volume 24 jam 501 rb). Perbedaan utamanya: Nippon Indosari Corpindo Tbk. jauh lebih besar — sekitar 22× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (592,2 rb vs 501 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | ROTI | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 3,8 T |
Volume | 592,2 rb | 501 rb |
Lot | 5,92 rb | 5,01 rb |
Perputaran | 147,05 jt | 307,52 jt |
Harga Rata-rata | 248,31 | 613,81 |
Nilai Transaksi | 147,05 jt | 307,52 jt |
Harga Ekuilibrium Indikatif | 254 | 610 |
Volume Ekuilibrium Indikatif | 10 | 1,67 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman ROTI →